Antibody Therapeutics Patients First!

공지사항


번호 제목 작성자 작성일 조회
65   [KSMO 2019] Invitation Letter_Dr. Jin-San Yoo   관리자   2019-03-27   520  
64   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a lecture at DGIST Brain and Cognitive Sciences   관리자   2019-02-07   1,091  
63   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at the 2nd Korean Immuno-Oncology Symposium 2019 March 8th,   관리자   2019-02-07   541  
62   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to host CEO Roundtable at WuXi Healthcare Forum 2019 March 5-6,   관리자   2019-02-07   503  
61   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to attend to JP Morgan's Korea Conference 2019 (February 21-22).   관리자   2019-02-07   700  
60   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine was invited to attend as MAB working group expert for EDQM MAB Experts meeting   관리자   2019-02-07   502  
59   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, Dr. Weon Sup Lee, Head of R&D Center, Dr. Sung Woo Kim, Head of BD were invited by JP Morgan Healthcare Confe   관리자   2019-02-07   541  
58   파멥신, 2018 제12회 하반기 대한민국 우수특허 大賞   관리자   2019-01-04   4,507  
57   Quarterly Magazine KoNECT 14호(2018.12)_Interview of Dr. Jin-San Yoo   관리자   2019-01-04   615  
56   PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Weon Sup Lee, Head of R&D center and PharmAbcine R&D staffs have attended and presented their R&D progress of both TTAC-0001 (Tanibirumab) and PMC-309 projects funded by KDDF   관리자   2018-09-10   4,388